NYSE:BCSF - Bain Capital Specialty Finance Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $18.96 -0.04 (-0.21 %) (As of 05/24/2019 04:00 PM ET)Previous Close$19.00Today's Range$18.85 - $18.9852-Week Range$15.14 - $20.90Volume1,875 shsAverage Volume152,144 shsMarket Capitalization$979.28 millionP/E Ratio13.09Dividend Yield8.63%BetaN/A ProfileAnalyst RatingsChartDividendEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million. Receive BCSF News and Ratings via Email Sign-up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Holding & other investment offices Sub-IndustryN/A SectorFinance Current SymbolNYSE:BCSF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.baincapitalbdc.com/ Phone617-516-2000Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.17Price-To-Earnings Trailing P/E Ratio13.09 Forward P/E Ratio10.96 P/E Growth3.63 Sales & Book Value Annual Sales$99.29 million Price / Sales9.86 Cash Flow$1.0979 per share Price / Cash Flow17.27 Book Value$19.75 per share Price / Book0.96Profitability EPS (Most Recent Fiscal Year)$1.45 Net Income$26.65 million Net Margins44.85% Return on Equity7.23% Return on Assets4.02%Miscellaneous EmployeesN/A Outstanding Shares51,650,000Market Cap$979.28 million Next Earnings Date8/14/2019 (Estimated) OptionableNot Optionable Bain Capital Specialty Finance (NYSE:BCSF) Frequently Asked Questions What is Bain Capital Specialty Finance's stock symbol? Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF." How often does Bain Capital Specialty Finance pay dividends? What is the dividend yield for Bain Capital Specialty Finance? Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, May 8th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.41 per share on Monday, July 29th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 8.70%. The ex-dividend date is Thursday, June 27th. View Bain Capital Specialty Finance's Dividend History. How were Bain Capital Specialty Finance's earnings last quarter? Bain Capital Specialty Finance Inc (NYSE:BCSF) issued its quarterly earnings data on Wednesday, May, 8th. The company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.42 by $0.01. The firm earned $39.89 million during the quarter, compared to analyst estimates of $41.83 million. Bain Capital Specialty Finance had a net margin of 44.85% and a return on equity of 7.23%. View Bain Capital Specialty Finance's Earnings History. When is Bain Capital Specialty Finance's next earnings date? Bain Capital Specialty Finance is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Bain Capital Specialty Finance. What price target have analysts set for BCSF? 5 analysts have issued 1-year target prices for Bain Capital Specialty Finance's stock. Their predictions range from $20.00 to $20.50. On average, they anticipate Bain Capital Specialty Finance's stock price to reach $20.25 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price. View Analyst Price Targets for Bain Capital Specialty Finance. What is the consensus analysts' recommendation for Bain Capital Specialty Finance? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bain Capital Specialty Finance. Has Bain Capital Specialty Finance been receiving favorable news coverage? News stories about BCSF stock have been trending negative this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bain Capital Specialty Finance earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of Bain Capital Specialty Finance's key competitors? Some companies that are related to Bain Capital Specialty Finance include Verra Mobility (VRRM), CHURCHILL CAP C/SH (CCC), GS ACQUISITION /SH CL A (GSAH), Global Cord Blood (CO), Vantage Energy Acquisition (VEAC), HAYMAKER ACQUIS/SH CL A (HYAC), Pensare Acquisition (WRLS), THUNDER BRDG AC/SH SH (TBRG), FORUM MERGER II/SH CL A (FMCI), ANDINA ACQUISIT/SH SH (ANDA), AgroFresh Solutions (AGFS), KBL MERGER CORP/SH (KBLM), Jetpay (JTPY), CM SEVEN STAR A/SH SH (CMSS) and Alta Mesa Resources (AMR). What other stocks do shareholders of Bain Capital Specialty Finance own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Cisco Systems (CSCO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Amgen (AMGN), CSX (CSX), Johnson & Johnson (JNJ) and Mcdonald's (MCD). Who are Bain Capital Specialty Finance's key executives? Bain Capital Specialty Finance's management team includes the folowing people: Mr. Michael Alexander Ewald, Pres, CEO & Director (Age 45)Ms. Sally Fassler Dornaus CPA, CPA, Chief Financial Officer (Age 44)Mr. Derek Kirby, Investor ContactMr. James Goldman, Chief Compliance Officer (Age 42)Mr. James S. Athanasoulas, VP & Treasurer (Age 45) When did Bain Capital Specialty Finance IPO? (BCSF) raised $156 million in an initial public offering (IPO) on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities acted as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers. Who are Bain Capital Specialty Finance's major shareholders? Bain Capital Specialty Finance's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Starr International Co. Inc. (1.34%), Muzinich & Co. Inc. (1.05%), C.V. Starr & Co. Inc. Trust (0.67%), Bank of Montreal Can (0.16%), Morgan Stanley (0.14%) and BlackRock Inc. (0.07%). Company insiders that own Bain Capital Specialty Finance stock include Jeffrey B Hawkins, Michael A Ewald and Michael John Boyle. View Institutional Ownership Trends for Bain Capital Specialty Finance. Which major investors are selling Bain Capital Specialty Finance stock? BCSF stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley. View Insider Buying and Selling for Bain Capital Specialty Finance. Which major investors are buying Bain Capital Specialty Finance stock? BCSF stock was bought by a variety of institutional investors in the last quarter, including Starr International Co. Inc., Muzinich & Co. Inc., C.V. Starr & Co. Inc. Trust, Bank of Montreal Can, BlackRock Inc., Stephens Inc. AR, Virtu Financial LLC and Wells Fargo & Company MN. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Jeffrey B Hawkins, Michael A Ewald and Michael John Boyle. View Insider Buying and Selling for Bain Capital Specialty Finance. How do I buy shares of Bain Capital Specialty Finance? Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bain Capital Specialty Finance's stock price today? One share of BCSF stock can currently be purchased for approximately $18.86. How big of a company is Bain Capital Specialty Finance? Bain Capital Specialty Finance has a market capitalization of $974.12 million and generates $99.29 million in revenue each year. The company earns $26.65 million in net income (profit) each year or $1.45 on an earnings per share basis. What is Bain Capital Specialty Finance's official website? The official website for Bain Capital Specialty Finance is http://www.baincapitalbdc.com/. How can I contact Bain Capital Specialty Finance? Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected] MarketBeat Community Rating for Bain Capital Specialty Finance (NYSE BCSF)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 14 (Vote Outperform)Underperform Votes: 18 (Vote Underperform)Total Votes: 32MarketBeat's community ratings are surveys of what our community members think about Bain Capital Specialty Finance and other stocks. Vote "Outperform" if you believe BCSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCSF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: How to trade on quiet period expirations Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.